Immunotherapy Linked to Lower Relapse Risk in MOGAD
Treatment with immunotherapy is tied to a lower risk for relapse in patients with myelin oligodendrocyte glycoprotein antibody disease (MOGAD), new research shows.
Stay updated with breaking news from Multiple Sclerosis Ms. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Treatment with immunotherapy is tied to a lower risk for relapse in patients with myelin oligodendrocyte glycoprotein antibody disease (MOGAD), new research shows.
Next generation wearable devices that measure function with a high degree of precision promise to detect earlier changes in multiple sclerosis and differentiate between different subtypes of MS.
Experts are leading an initiative to drive home the message that clinicians must consider MS in the differential diagnosis for Black patients and others who present with symptoms of demyelination.
New study sheds light on psychiatric conditions that appear in the years prior to multiple sclerosis symptoms.
Patients with multiple sclerosis who cut calories 2 days per week not only lost weight in a new study, they also showed better cognition and other positive outcomes.